Related Experiment Video
Updated: Dec 29, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss
Giacomina Brunetti1, Giuseppina Storlino2, Angela Oranger2
1Department of Basic and Medical Sciences, Neurosciences and Sense Organs, Section of Human Anatomy and Histology, University of Bari, Bari, Italy.
Ovariectomy causes bone loss by increasing the T-cell cytokine LIGHT, which affects bone cell activity. Blocking LIGHT may treat postmenopausal osteoporosis by preventing bone loss.
Area of Science:
- Immunology
- Bone Biology
- Endocrinology
Background:
- Ovariectomy-induced bone loss involves complex cellular and molecular mechanisms.
- The precise role of immune cells and cytokines in this process remains incompletely understood.
Purpose of the Study:
- To investigate the role of the T-cell co-stimulatory cytokine LIGHT in ovariectomy-induced bone loss.
- To explore LIGHT as a potential therapeutic target for postmenopausal osteoporosis.
Main Methods:
- Utilized LIGHT-deficient (Tnfsf14-/-) and lymphocyte-deficient (Rag-/-Tnfsf14-/-) mouse models.
- Assessed bone mass and analyzed cytokine expression (TNF, OPG, RANKL) following ovariectomy.
- Measured LIGHT levels in circulating immune cells of postmenopausal osteoporosis patients.
Main Results:
- Ovariectomy increased LIGHT levels, stimulating both osteoblastogenesis and osteoclastogenesis.
- LIGHT-deficient mice were protected from ovariectomy-induced bone loss.
- Postmenopausal osteoporosis patients showed elevated LIGHT in T cells and monocytes.
Conclusions:
- LIGHT is a key mediator of bone loss following ovariectomy.
- Targeting LIGHT may offer a novel therapeutic strategy for postmenopausal osteoporosis.
More Related Videos
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...